International Hepato-Pancreato-Biliary Association
New Analysis Reveals First-Line Treatment Data on SIR-Spheres® Y-90 resin microspheres for Patients with Liver Metastases from Right-Sided Primary Colon Cancer
SIRFLOX and FOXFIRE Global findings suggest that adding liver-directed Selective Internal Radiation Therapy (SIRT) to standard first-line chemotherapy may improve overall survival in metastatic...
AngioDynamics Announces FDA Clearance for The Solero Microwave Tissue Ablation System
ALBANY, N.Y., June 07, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease...
SIR-Spheres® Y-90 Resin Microspheres Showed no Significant Difference in Overall Survival (OS) Compared to Sorafenib in Advanced HCC with Significantly Fewer Severe Adverse Events, New Asia-Pacific Study Finds
Final Results of SIRveNIB Study presented at 2017 American Society of Clinical Oncology Meeting Chicago, IL, USA (5 June 2017) -- For the second time in less than two months, a major head-to-head...
Metastatic colorectal cancer patients treated first-line with SIR-Spheres® Y-90 resin microspheres more likely to become candidates for potentially curative liver surgery, REsect study shows
Surgeons’ blinded assessment of pre- and post-treatment CT scans of patients with previously unresectable colorectal cancer liver metastases treated in the SIRFLOX study presented at 12th Annual...
AngioDynamics Receives CE Mark Certification for The Solero Microwave Tissue Ablation System
ALBANY, N.Y., March 14, 2017 (GLOBE NEWSWIRE) - - AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease...
If you are interested in becoming a Corporate Partner of the IHBPA please contact firstname.lastname@example.orgFind out more